Female Power Broker
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yea.... BAM baby! woo hoo
$zero soon
When you can just print more for free, it doesn't really matter.. Does it?
LP takes 5 X the average CEO annual salary! Without her stock and bonuses!
<<< $165,598/ year Avg. Base Salary (USD) >>>
https://www.payscale.com/research/US/Job=Chief_Executive_Officer_(CEO)/Salary
Suckers
Don't expect either.
You will experience more disappointment
""" NWBO has a huge head start on this particular segment of immunotherapies."""
Yea, a 25 year head start... Like Blockbuster Video!!!
Clown
"Contradictions do not exist. Whenever you think you are facing a contradiction, check your premises. You will find that one of them is wrong."
~Rand
Talk to an adult who actually knows things...
If you want to make your money back, look at MNMD, CMPS and CYBN for speculative purchases.
DR "High" on his own supply
Tell LP to stop printing shares!
Advent will eventually be sold for over $1 Billion,
MWBO shareholders' end is $0.00
LP and Toucan will get almost all of it.
JMO
Looks like about 23,913,043 shares at current share price...
Not including interest or the 10% pre payment penalty if they pay it off early
How many shares will be printed to offset an $11 million ( plus interest) loan repayment at .46 cents per share?
That is the real question.
It does seem like the company has completed the intense work of legally disclosing their salary raises, setting up for more bonuses and arranging another dilutive loan and now have time to attend to other matters, notably addressing the RFI...
There, fixed it for ya.
JMHO.
Getting payments in C Shares, and most likely an anti dilution clause of some kind. Also most likely where most of the increase in outstanding shares is coming from on an almost daily basis. .
IMO
The real dilution hasn't even come yet...
JMHO
NWBO has nowhere else to go for the money. Seems they were made for each other.
More weakness in share price and more dilution will come when the stock issued for that loan starts hitting the market.
You poor boys have been begging for "news" and the only news you get is more dilution via toxic loans, and bigger salaries and more bonuses to come for management.
I feel sorry for anyone losing money here.
My posts are my opinions
They are getting paid in stock and selling it... As far as I know
More C shares in the printing press!!!
Salaries and bonuses need to get funded.
She's right... But NWBO is still going to zero IMO-
Yes to what she opined... .... oh and by the way she works for UCLA.... Only gets paid by you bag holders for credibility of the OTCBB stock scam...
Wise up son... You have been had.
All posts are my opinions
And it seems U of F, Moderna and IBRX are leading the way.
Cool
Nothing yet from the silent corrupt scam company, as usual.. One of their anonymous surrogates will opine soon.
Doesn't change the fact that it will most likely be granted. The flim flam is just about over.
All posts are my opinions
Did I break any laws? No, I didn't think so.
Apparently you are a very bad investor... Your AVXL is at a 4 year low, and your NWBO investment is down over 99% in the last decade.
Focus on yourself, little man.
What about Liau, Brem, Iwamoto, Pluward, Prins, and Pearlman????? LOL
This whole thing is a laughing fest. The trial failed and they tried using band aids 4 years later... That is why it's an OTCBB stock scam, seeking tiny approval in the neither-lands of the UK, and it's doubtful there also... .... IMHO
You don't have to cover when it hits zero
EXPERTS?????
First of all, JAMA does not approve drugs. LOL
Secondly, that is over 2 years old
Thirdly: The conflicts here are enormous!
*******Drs Boynton and Bosch reported being employees of and owning shares in Northwest Biotherapeutics, Inc. Dr Boynton reported having a patent held by Northwest Biotherapeutics. Dr Bosch reporting having patent 13/492693 pending.Conflict of Interest *****
Disclosures: Dr Liau reported serving on the board of directors of ClearPoint Neuro outside the submitted work and having a patent pending for combinations of inhibitors with dendric cell vaccines to treat cancer. Dr Ashkan reported receiving grants from Northwest Biotherapeutics during the conduct of the study. Dr Brem reported receiving travel support from Northwest Biotherapeutics outside the submitted work. Dr Campian reported receiving grants from NeoImmue Tech and support for investigator-initiated clinical trials from Incyte, Merck, and Ipsen outside the submitted work. Dr Iwamoto reported receiving grants from Northwest Biotherapeutics and serving on the steering committee of this trial during the conduct of the study and receiving personal fees from AbbVie, Alexion, Gennao Bio, Novocure, Kiyatec, Medtronic, Merck, Guidepoint, Mimivax, Massive Bio, Tocagen, Regeneron, and Xcures outside the submitted work. Dr Tran reported receiving grants from Novocure, Moteris, Lacerta, Sarepta, Merck, Novartis, Northwest Biotherapeutics, Stemline, Celldex, Orbus, TVax, and Tocagen; receiving travel support from Novartis; and serving on the advisory board of Novocure during the conduct of the study. Dr Goldlust reported receiving institutional support from Northwest Biotherapeutics during the conduct of the study; receiving consulting fees from Boston Biomedical, Sumitomo Danippon Pharma, Cornerstone Specialty Network, Cellevolve, Daiichi Sankyo, and Novocure; serving on the speakers’ bureau for Novocure and Physicians Education Resources; receiving food and drink from Novocure; and owning stock in COTA outside the submitted work. Dr Grewal reported receiving personal fees from AstraZeneca, Vivacitas Oncology, and xCures; receiving sample medication from AbbVie/Allergan; and being the founder of Genomet outside the submitted work. Dr Avigan reported serving on the advisory boards of Bristol Myer Squibb, Chugai, Merck, Kite, and Legend; receiving grants from Sanofi, and serving as a consultant for Parexel outside the submitted work. Dr Fink reported receiving funding from Northwest Biotherapeutics during the conduct of the study and receiving funding from Novocure, Denovo Biopharma, Stemline, CNS Pharmaceuticals, Servier Pharmaceuticals/Agios, and Sumitoma Pharma outside the submitted work. Dr Giglio reported receiving study support from the Medical University of South Carolina during the conduct of the study; receiving grants from Denovo Biopharma, Novocure, BioMimetix, Celgene, EORTC, the Canadian Cancer Trials Group, Institut de Recherches Internationales Servier, the Global Coalition for Adapative Research, and Prelude outside the submitted work; and having a patent pending for the epitranscriptomic analysis of glioma. Dr Lutzky reported receiving grants from Bristol Myer Squibb and serving on the advisory boards of Iovance and Castle outside the submitted work. Dr Meisel reported receiving personal fees from BG Klinikum Bergmannstrost during the conduct of the study and receiving consulting fees paid to Regenerate Life Sciences from Stayble Therapeutics and royalties from Fehling Instruments outside the submitted work. Dr Sanchin reported receiving personal fees from BG Klinikum Bergmannstrost during the conduct of the study. Dr Dunbar reported receiving speaking fees from GT Medical during the conduct of the study. Dr Pluward reported receiving grants from Northwest Biotherapeutics during the conduct of the study. Dr Mulholland reported receiving support to attend a conference from Northwest Biotherapeutics during the conduct of the study. Dr Pearlman reported receiving compensation for serving as a site principal investigator from Northwest Biotherapeutics during the conduct of the study. Dr Prins reported having patent UCLA Case No. 2015-341 pending. Drs Boynton and Bosch reported being employees of and owning shares in Northwest Biotherapeutics, Inc. Dr Boynton reported having a patent held by Northwest Biotherapeutics. Dr Bosch reporting having patent 13/492693 pending.
DCVax is like an 8 track cassette tape,... that doesn't work.
RNA is all the rage
https://www.sciencedaily.com/releases/2024/05/240501125736.htm
"Thanks for contacting GOV.UK.
Your query has been passed to the Medicines and Healthcare Products Regulatory Agency, who manage this material. They will investigate and respond to you directly. Unfortunately, we can't give an estimated time when the department will reply.
In the meantime your original query with GOV.UK will be closed.". CLOSED? LOL And some here on this board think they work on weekends and Holidays... 🤣
And it took a week to even get that lame response.
LOL that was for one question, Imaging trying to get a cancer therapy approved?????
Let's see what you know, shall we? I'll start with a few easy questions.
Has an RFI been issued by MHRA ?
Was an RFI not issued, and MHRA went directly to phase 2 of the assessment process?
What is the revenue split with Advent, how many patients will be eligible for DCVax and how many treatments will NICE reimburse in the UK?
These are things that any person who has any amount of money invested here should know.
<<< We need a capital infusion from a partner and likely should have seeked one years ago >>>
1 million LOLs
No legitimate , respectable organization wants any part of this stock scam ( IMHO)
Evidenced by the dilutive drip drip drip clandestine funding efforts and lack of institutional ownership,... which is as close to zero as possible without being an actual $ZERO!.
She's on the OTCBB for a reason, genius. And there is also a reason for choosing MHRA as opposed to all legit RAs.
I am immensely amused by your reference as "we" ... lol. There is no "WE" with LP , Toucan, Cognate and Advent... it's all "SHE"
<<< Yes its possible to structure debt which becomes 100% nondilutive >>>
Really???? How's that? Kars for Kids? Another million LOLs
Dude-ess, please...
I think it's eventually going to $0.0005
I don't think they can even get a mere UK approval without running the pediatric trials... Everyone is ignoring this elephant in the room .... PS , from what I've seen, they ARE idiots. IMO
https://www.gov.uk/guidance/procedures-for-uk-paediatric-investigation-plan-pips
Institutional Shares (Long) 569,127 - 0.05% of outstanding shares( LOL)
change of -2.55MM shares -82.32% MRQ
What a racket!!!!
While you guys have a stock that has gone down 99.999% in the last 10 years!
Magnificent scandal.... IMHO
""" Nature publication…. Could be just ahead."""
So could bankruptcy, it could substantially change the narrative, overnight.
NWBO could file bankruptcy, have Revimmune take it over for nothing while management retains all their shares in the new entity...
Just thinking my opinions out loud here...
Paul Allen’s Charter Stiffs Common Shareholders
Allen, 55, holds some of that debt that can be converted to stock and will retain voting control of the company.
For Allen, a billionaire recently ranked by Forbes as the 12th richest man in America with a net worth of $16 billion, the deal allows Charter to live for another day. For common stockholders, though, the bet on Allen was a bust
In the process, Charter left its common stockholders holding an empty bag.
How does Paul Allen remain the main shareholder while all of the shareholders’ stock is worthless? THIS SOUNDS LIKE ANOTHER RIP OFF,
https://www.eweek.com/it-management/paul-allen-s-charter-stiffs-common-shareholders/
<<< Let’s say NWBO gets approved, I don’t see how they won’t >>>
That... is your problem! IMO
"Contradictions do not exist. Whenever you think you are facing a contradiction, check your premises. You will find that one of them is wrong."
~Rand
Yup, that's a fact!!!
05/01/24 - 1,206,257,975
04/27/24 - 1,205,420,320
04/26/24 - 1,205,197,045
04/23/24 - 1,204,236,917
04/20/24 - 1,204,039,742
04/17/24 - 1,203,973,067
04/12/24 - 1,203,199,607
04/11/24 - 1,201,099,732
Nobody is shorting!!!! Your fearless leader is selling stock like lemonade !!!!
<<< In England, around 2,200 cases >>
In 10 years of C Care, NWBO got almost ZERO of them
Why would there be? It doesn't work anywhere except bagholder land.
Don't look now but your stock is heading towards ZERO....
Maybe when it hits ZERO, Merck will buy it for $25 Billion ... lol - morons
Dr. High is a bag holder who finally realized he got screwed and still hasn't figured out how to deal with the emotions yet... Feel sorry for him and you guys.
Down 99.999% in 10 years and about to go down another 99.999%... dirt road,... kids
I refuse to enter a battle of wits with an unarmed opponent...
Enjoy watching your stock become worthless